Clinical Trials Directory

Trials / Completed

CompletedNCT01462227

Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia

The Effect of Opiate Blockade With Naltrexone on Counterregulatory Mechanisms in Hypoglycemia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Insulin treatment often causes the blood glucose levels to fall too low. The body usually responds to low blood glucose levels by releasing hormones which act against the insulin to help correct the low blood glucose levels. However, this hormone response can be altered in people with diabetes. Currently there are no therapeutic agents that can be used to improve the recovery from hypoglycemia (low blood sugar). Naltrexone is a tablet used to help people who are addicted to alcohol or morphine-based drugs to remain drug and alcohol-free but it can also affect the levels of the hormones which are released during hypoglycemia. The aim of this study is to determine whether naltrexone can be used to improve and accelerate the recovery from hypoglycemia in patients with type 1 diabetes.

Conditions

Interventions

TypeNameDescription
DRUGNaltrexone High DoseNaltrexone 100mg for two administrations.
DRUGNaltrexone Low DoseNaltrexone 50mg for two administrations.

Timeline

Start date
2011-08-01
Primary completion
2013-10-01
Completion
2013-10-01
First posted
2011-10-31
Last updated
2016-02-18
Results posted
2016-02-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01462227. Inclusion in this directory is not an endorsement.